Imagine your vision starts to blur, partially at first, maybe even in just one eye, but over time it starts to get worse. And when you talk to your doctor about it, you may discover you're one of just ...

A new treatment for a debilitating genetic disease causing sudden sight loss is now available on the NHS in England. Evidence ...

Researchers from Landeskrankenhaus Salzburg (SALK) - Universitätsklinikum der PMU have identified a novel loss-of-function variant in the NDUFA7 gene in a patient with Leber’s hereditary optic ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending idebenone (Raxone, Chiesi Pharmaceuticals) for treating visual impairment from Leber ...

There is a simple discount patient access scheme for idebenone. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

After considering the feedback from consultation, the appraisal committee has prepared final draft guidance (FDG) on idebenone for treating visual impairment in Leber’s hereditary optic neuropathy in ...